Reumatología y Enfermedades Inmuno-Mediadas (IRIDIS)

Altabas-Gonzalez I, Pego-Reigosa JM, Mourino C, Jimenez N, Hernandez-Martin A,Casafont-Sole I, Font Urguelles J, Roman-Ivorra JA, de la Rubia Navarro M,Galindo-Izquierdo M, Salman-Monte TC, Narvaez J, Vidal-Montal P,Garcia-Villanueva MJ, Garrote-Corral S, Blazquez-Canamero MA, Marras C,Piqueras-Garcia M, Martinez-Barrio J, Sanchez-Lucas M, Cortes-Hernandez J, PenzoE, Calvo-Alen J, de Dios JR, Alvarez Rodriguez B, Vasques-Rocha M, Tomero E,Menor-Almagro R, Gandia M, Gomez-Puerta JA, Frade-Sosa B, Ramos-Giraldez C,Trapero-Perez C, Diez E, Moriano C, Munoz-Jimenez A, Rua-Figueroa IJ. Thoroughassessment of the effectiveness of belimumab in a large Spanish multicentercohort of systemic lupus erythematosus patients. Rheumatology (Oxford). 2025 Jan1;64(1):276-282. doi: 10.1093/rheumatology/kead696. PubMed PMID: 38490245; PubMedCentral PMCID: PMC11701321.

Davina-Nunez C, Perez-Castro S, Cabrera-Alvargonzalez JJ, Gonzalez-Alonso E,Silva-Bea S, Rodriguez-Perez M, Figueroa-Lamas MDP, Perez-Gonzalez A, Del CampoV, Rojas A, Mendoza J, Regueiro-Garcia B. Subgenomic RNA and LimitedCross-Reactive Neutralising Antibodies Point to Potential Improvements inSARS-CoV-2 Clinical Handling. Int J Mol Sci. 2025 Mar 24;26(7):2948. doi:10.3390/ijms26072948. PubMed PMID: 40243564; PubMed Central PMCID: PMC11988571.

Rua-Figueroa I, Altabas-Gonzalez I, Mourino C, Roberts K, Hernandez-Martin A,Casafont-Sole I, Font-Urgelles J, Roman-Ivorra JA, de la Rubia Navarro M,Galindo-Izquierdo M, Salman-Monte TC, Narvaez J, Vidal-Montal P,Garcia-Villanueva MJ, Garrote-Corral S, Blazquez-Canamero MA, Fernandez-Cid CM,Piqueras-Garcia M, Martinez-Barrio J, Sanchez-Lucas M, Cortes-Hernandez J, PenzoE, Calvo-Alen J, de Dios JR, Alvarez-Rodriguez B, Vasques-Rocha M, Tomero E,Menor-Almagro R, Gandia M, Gomez-Puerta JA, Frade-Sosa B, Ramos-Giraldez C,Trapero-Perez C, Diez E, Moriano C, Munoz-Jimenez A, Pego-Reigosa JM. Can thedose of belimumab be reduced in patients with systemic lupus erythematosus?Rheumatology (Oxford). 2025 Mar 1;64(3):1220-1224. doi:10.1093/rheumatology/keae270. PubMed PMID: 38741198.

Altabas-Gonzalez I, Rua-Figueroa I, Mourino C, Roberts K, Jimenez N,Martinez-Barrio J, Galindo M, Calvo Alen J, Perez VDC, Uriarte Itzazelaia E,Tomero E, Freire-Gonzalez M, Martinez Taboada V, Salgado E, Vela P,Fernandez-Nebro A, Olive A, Narvaez J, Menor-Almagro R, Soler GS,Hernandez-Beriain JA, Manero J, Aurrecoechea E, Ibarguengoitia-Barrena O,Montilla C, Bonilla G, Torrente-Segarra V, Cacheda AP, Garcia-Villanueva MJ,Moriano-Morales C, Manteca CF, Lozano-Rivas N, Bohorquez C, Pego-Reigosa JM.Damage in a large systemic lupus erythematosus cohort from the Spanish Society ofRheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascularsystem: a longitudinal analysis. Lupus Sci Med. 2024 Aug 3;11(2):e001064. doi:10.1136/lupus-2023-001064. PubMed PMID: 39097409; PubMed Central PMCID:PMC11331961.

Altabas-Gonzalez I, Rua-Figueroa I, Rubino F, Mourino C, Hernandez-RodriguezI, Menor-Almagro R, Uriarte-Isacelaya E, Tomero E, Salman-Monte TC,Carrion-Barbera I, Galindo-Izquierdo M, Rodriguez-Almaraz ME, Ines LS, Jimenez N,Pego-Reigosa JM. Does remission in systemic lupus erythematosus according to the2021 DORIS definition match the treating rheumatologist’s judgement? Rheumatology(Oxford). 2024 Jan 4;63(1):72-78. doi: 10.1093/rheumatology/kead159. PubMed PMID:37039851; PubMed Central PMCID: PMC10765144.

Blanco-Perez J, Salgado-Barreira A, Blanco-Dorado S, Gonzalez Bello ME,Caldera Diaz AC, Perez-Gonzalez A, Pallares Sanmartin A, Fernandez Villar A,Gonzalez-Barcala FJ. Clinical usefulness of serum angiotensin converting enzymein silicosis. Pulmonology. 2024 Jul-Aug;30(4):370-377. doi:10.1016/j.pulmoe.2022.06.002. Epub 2022 Oct 22. PubMed PMID: 36280590.

Cabrera-Alvargonzalez JJ, Davina-Nunez C, Rey-Cao S, Rodriguez Calvino L,Silva-Bea S, Gonzalez-Alonso E, Carballo-Fernandez R, Lameiro Vilarino C,Cortizo-Vidal S, Valino-Prieto P, Rodriguez-Perez M, Perez Castro S, LopezMiragaya I, Fernandez-Nogueira A, Del Campo-Perez V, Regueiro-Garcia B.Comparative analysis of eleven SARS-CoV-2 immunoassays and neutralisation data:time to enhance standardisation and correlation of protection. Infect Dis (Lond).2024 Dec;56(12):1067-1079. doi: 10.1080/23744235.2024.2382263. Epub 2024 Jul 24.PubMed PMID: 39046827.
Enlace

Carvalheiro T, Marut W, Pascoal Ramos MI, Garcia S, Fleury D, Affandi AJ,Meijers AS, Giovannone B, Tieland RG, Elshof E, Ottria A, Cossu M, Meizlish ML,Veenendaal T, Ramanujam M, Moreno-Garcia ME, Klumperman J, Liv N, Radstake TRDJ,Meyaard L. Impaired LAIR-1-mediated immune control due to collagen degradation infibrosis. J Autoimmun. 2024 Jun;146:103219. doi: 10.1016/j.jaut.2024.103219. Epub2024 May 1. PubMed PMID: 38696927.

Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, BoletisJ, Bruce IN, Cervera R, Doria A, Dorner T, Furie RA, Gladman DD, Houssiau FA,Ines LS, Jayne D, Kouloumas M, Kovacs L, Mok CC, Morand EF, Moroni G, Mosca M,Mucke J, Mukhtyar CB, Nagy G, Navarra S, Parodis I, Pego-Reigosa JM, Petri M,Pons-Estel BA, Schneider M, Smolen JS, Svenungsson E, Tanaka Y, Tektonidou MG,Teng YO, Tincani A, Vital EM, van Vollenhoven RF, Wincup C, Bertsias G, BoumpasDT. EULAR recommendations for the management of systemic lupus erythematosus:2023 update. Ann Rheum Dis. 2024 Jan 2;83(1):15-29. doi: 10.1136/ard-2023-224762.PubMed PMID: 37827694.

Garcia S. Microbiome status as a predictive tool for response to therapy inrheumatoid arthritis. Rheumatology (Oxford). 2024 Dec 1;63(12):3199-3200. doi:10.1093/rheumatology/keae292. No abstract available. PubMed PMID: 38754109.

Garcia-Villanueva MJ, Garrote-Corral S, Pego-Reigosa JM, Jimenez Otero N,Uriarte Isazelaia E, Olive Marque A, Sanguesa Gomez C, Freire Gonzalez M,Aurrecoechea Aguinaga E, Raya Alvarez E, Tomero Muriel E, Montilla Morales C,Galindo Izquierdo M, Calvo-Alen J, Menor-Almagro R, Serrano Benavente B,Martinez-Barrio J, Hernandez-Beriain JA, Ibanez Barcelo M, Bonilla Hernan G,Rosas J, Salgado Perez E, Fernandez-Nebro A, Rua-Figueroa I. Diffuse alveolarhemorrhage in patients with systemic lupus erythematosus: data from the Spanishsociety of rheumathology Lupus Register (RELESSER). Rheumatol Int. 2024Nov;44(11):2445-2455. doi: 10.1007/s00296-024-05684-4. Epub 2024 Aug 24. PubMedPMID: 39180523.

Martinez-Ramos S, Garcia S. An update of murine models and their methodologiesin immune-mediated joint damage and pain research. Int Immunopharmacol. 2024 Feb15;128:111440. doi: 10.1016/j.intimp.2023.111440. Epub 2024 Jan 4. PubMed PMID:38176343.

Martinez-Ramos S, Rafael-Vidal C, Malvar-Fernandez B, Perez N, Mourino C,Perez SG, Maceiras Pan FJ, Conde C, Pego-Reigosa JM, Garcia S. Semaphorin3Bpromotes an anti-inflammatory and pro-resolving phenotype in macrophages fromrheumatoid arthritis patients in a MerTK-dependent manner. Front Immunol. 2024Jan 12;14:1268144. doi: 10.3389/fimmu.2023.1268144. eCollection 2023. PubMedPMID: 38283352; PubMed Central PMCID: PMC10811190.

Mena-Vazquez N, Redondo-Rodriguez R, Rojas-Gimenez M, Romero-Barco CM,Fuego-Varela C, Perez-Gomez N, Anon-Onate I, Castro Perez P, Garcia-Studer A,Hidalgo-Conde A, Arnedo Diez de Los Rios R, Cabrera-Cesar E, Velloso-Feijoo ML,Manrique-Arija S, Calvo-Gutierrez J, Gandia-Martinez M, Morales-Garrido P,Godoy-Navarrete FJ, Mourino-Rodriguez C, Espildora F, Aguilar-Hurtado MC,Fernandez-Nebro A. Rate of severe and fatal infections in a cohort of patientswith interstitial lung disease associated with rheumatoid arthritis: amulticenter prospective study. Front Immunol. 2024 Mar 28;15:1341321. doi:10.3389/fimmu.2024.1341321. eCollection 2024. PubMed PMID: 38605950; PubMedCentral PMCID: PMC11007097.

Perez-Jurado LA, Caceres A, Balague-Dobon L, Esko T, Lopez de Heredia M,Quintela I, Cruz R, Lapunzina P, Carracedo A; SCOURGE Cohort Group [Victor Del Campo, Esteban Castelao]; Gonzalez JR. Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increasevulnerability for SARS-CoV-2. Commun Biol. 2024 Feb 19;7(1):202. doi:10.1038/s42003-024-05805-6. PubMed PMID: 38374351; PubMed Central PMCID:PMC10876565.

Rafael-Vidal C, Martinez-Ramos S, Malvar-Fernandez B, Altabas-Gonzalez I,Mourino C, Pazos-Lopez P, Fraga-Bau A, Pego Reigosa JM, Garcia S. Novelendothelial progenitor cells populations as biomarkers of damage and remission insystemic lupus erythematosus. Arthritis Res Ther. 2024 Sep 28;26(1):170. doi:10.1186/s13075-024-03397-4. PubMed PMID: 39342288; PubMed Central PMCID:PMC11438060.

Rua-Figueroa I, Garcia de Yebenes MJ, Martinez-Barrio J, Galindo Izquierdo M,Calvo Alen J, Fernandez-Nebro A, Menor-Almagro R, Carmona L, Tejera Segura B,Tomero E, Freire-Gonzalez M, Sanguesa C, Horcada L, Blanco R, Uriarte ItzazelaiaE, Narvaez J, Rosas Gomez de Salazar JC, Gomez-Sabater S, Morales CM, Andreu JL,Segarra VT, Aurrecoechea E, Perez A, Novoa Medina J, Salgado E, Lozano-Rivas N,Montilla C, Ruiz-Lucea E, Arevalo M, Iniguez C, Garcia-Villanueva MJ, Exposito L,Ibanez-Barcelo M, Bonilla G, Carrion-Barbera I, Erausquin C, Fragio Gil JJ,Pecondon A, Toyos FJ, Cobo T, Munoz-Jimenez A, Oller J, Nolla JM, Pego-ReigosaJM. SLESIS-R: an improved score for prediction of serious infection in patientswith systemic lupus erythematosus based on the RELESSER prospective cohort. LupusSci Med. 2024 Apr 8;11(1):e001096. doi: 10.1136/lupus-2023-001096. PubMed PMID:38589223; PubMed Central PMCID: PMC11015315.

Rua-Figueroa I, Salman-Monte TC, Pego Reigosa JM, Galindo Izquierdo M, DiezAlvarez E, Fernandez-Nebro A, Roman Ivorra JA, Calvo Penades I, Artaraz BeobideJ, Calvo Alen J. Multidisciplinary consensus on the use of hydroxychloroquine inpatients with systemic lupus erythematosus. Reumatol Clin (Engl Ed). 2024Jun-Jul;20(6):312-319. doi: 10.1016/j.reumae.2024.03.002. PubMed PMID: 38991825.

Altabas-Gonzalez I, Rua-Figueroa I, Rubino F, Mourino Rodriguez C,Hernandez-Rodriguez I, Menor Almagro R, Uriarte Isacelaya E, Tomero Muriel E,Salman-Monte TC, Carrion-Barbera I, Galindo M, Rodriguez Almaraz EM, Jimenez N,Ines L, Pego-Reigosa JM. Does expert opinion match the definition of lupus lowdisease activity state? Prospective analysis of 500 patients from a Spanishmulticentre cohort. Rheumatology (Oxford). 2023 Mar 1;62(3):1162-1169. doi:10.1093/rheumatology/keac462. PubMed PMID: 35961050; PubMed Central PMCID:PMC9977118.

Cabrera Alvargonzalez J, Larranaga Janeiro A, Perez Castro S, Martinez TorresJ, Martinez Lamas L, Davina Nunez C, Del Campo-Perez V, Suarez Luque S, RegueiroGarcia B, Porteiro Fresco J. Proof of concept of the potential of a machinelearning algorithm to extract new information from conventional SARS-CoV-2rRT-PCR results. Sci Rep. 2023 May 13;13(1):7786. doi:10.1038/s41598-023-34882-6. PubMed PMID: 37179356; PubMed Central PMCID:PMC10182547.

Laino-Pineiro MC, Rua-Figueroa I, Jimenez N, Lozano MJC, Martinez-Barrio J,Serrano B, Galindo-Izquierdo M, Nack A, Loricera J, Tomero-Muriel E,Ibanez-Barcelo M, Vazquez NM, Manrique-Arija S, Lorenzo NA, Narvaez J, Rosas J,Menor-Almagro R, Martinez-Taboada VM, Aurrecoechea-Aguinaga E, Horcada L,Ruiz-Lucea E, Raya E, Toyos FJ, Exposito L, Vela P, Freire-Gonzalez M,Moriano-Morales C, Bonilla-Hernan G, Ibanez TC, Lozano-Rivas N, Moreno M, AndreuJL, Ubiaga CLI, Torrente-Segarra V, Valls E, Velloso-Feijoo ML, Alcazar JL,Pego-Reigosa JM. Pregnancy outcomes in 1869 pregnancies in a large cohort fromthe Spanish Society of Rheumatology Lupus Register (RELESSER). Semin ArthritisRheum. 2023 Aug;61:152232. doi: 10.1016/j.semarthrit.2023.152232. Epub 2023 Jun13. PubMed PMID: 37348350.

Magro-Checa C, Ramiro S, Rua-Figueroa I, Jimenez N, Del Campo-Perez V,Martinez-Barrio J, Galindo-Izquierdo M, Calvo-Alen J, Uriarte-Isacelaya E,Tomero-Muriel E, Freire-Gonzalez M, Martinez-Taboada V, Salgado E, Vela P,Mena-Vazquez N, Olive A, Narvaez J, Menor-Almagro R, Santos-Soler G,Hernandez-Beriain JA, Manero-Ruiz J, Aurrecoechea-Aguinaga E, Ibarguengoitia O,Montilla-Morales C, Bonilla-Hernan G, Torrente-Segarra V, Salman-Monte T,Ros-Vilamajo I, Garcia-Villanueva MJ, Moriano-Morales C, Fito-Manteca C,Lozano-Rivas N, Bohorquez C, Pego-Reigosa JM. Central nervous system involvementin systemic lupus erythematosus: Data from the Spanish Society of RheumatologyLupus Register (RELESSER). Semin Arthritis Rheum. 2023 Feb;58:152121. doi:10.1016/j.semarthrit.2022.152121. Epub 2022 Oct 22. PubMed PMID: 36375359.

Martinez-Ramos S, Rafael-Vidal C, Malvar-Fernandez B, Rodriguez-Trillo A,Veale D, Fearon U, Conde C, Conde-Aranda J, Radstake TRDJ, Pego-Reigosa JM,Reedquist KA, Garcia S. HOXA5 is a key regulator of class 3 semaphorinsexpression in the synovium of rheumatoid arthritis patients. Rheumatology(Oxford). 2023 Jul 5;62(7):2621-2630. doi: 10.1093/rheumatology/keac654. PubMedPMID: 36398888; PubMed Central PMCID: PMC10321103.

Rafael-Vidal C, Martinez-Ramos S, Malvar-Fernandez B, Altabas-Gonzalez I,Mourino C, Veale DJ, Floudas A, Fearon U, Reigosa JMP, Garcia S. Type IInterferons induce endothelial destabilization in Systemic Lupus Erythematosus ina Tie2-dependent manner. Front Immunol. 2023 Dec 14;14:1277267. doi:10.3389/fimmu.2023.1277267. eCollection 2023. PubMed PMID: 38162654; PubMedCentral PMCID: PMC10756137.

Cobo-Ibanez T, Sanchez-Piedra C, Nuno-Nuno L, Castellvi I, Carrion-Barbera I,Romero-Bueno F, Narvaez J, Trallero-Araguas E, Tomero E, Ruiz-Lucea ME, Larena C,Carrasco Cubero C, Jovani V, Barbadillo C, Sivera F, Belzunegui J, Perez Gomez A,Gomez Gomez A, Delgado-Frias E, Pego-Reigosa JM, Joven B, Ibanez M,Martinez-Gonzalez O, Ruiz-Roman A, Camins J, Ortega-Castro R, Trenor Larra P,Rodriguez Lopez M, Freire M, Alcocer P, Holgado S, Rua-Figueroa I, Lozano N,Martinez-Barrio J. Myo-Spain: Spanish Registry of patients with idiopathicinflammatory myopathy. Methodology. Reumatol Clin (Engl Ed). 2022May;18(5):253-259. doi: 10.1016/j.reumae.2021.01.004. Epub 2021 Aug 13. PubMedPMID: 34400117.
Enlace

Cordero OJ, Vieitez I, Altabas I, Nuno-Nuno L, Villalba A, Novella-Navarro M,Peiteado D, Miranda-Carus ME, Balsa A, Varela-Calvino R, Gomez-Tourino I,Pego-Reigosa JM. Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort ofTreatment-Naive Early Arthritis Patients. Arch Immunol Ther Exp (Warsz). 2022 Mar18;70(1):12. doi: 10.1007/s00005-022-00649-6. PubMed PMID: 35304639; PubMedCentral PMCID: PMC8933303.

Cruz R, Diz-de Almeida S, Lopez de Heredia M, Quintela I, Ceballos FC, Pita G,Lorenzo-Salazar JM, Gonzalez-Montelongo R, Gago-Dominguez M, Sevilla Porras M,Tenorio Castano JA, Nevado J, Aguado JM, Aguilar C, Aguilera-Albesa S, AlmadanaV, Almoguera B, Alvarez N, Andreu-Bernabeu A, Arana-Arri E, Arango C, Arranz MJ,Artiga MJ, Baptista-Rosas RC, Barreda-Sanchez M, Belhassen-Garcia M, Bezerra JF,Bezerra MAC, Boix-Palop L, Brion M, Brugada R, Bustos M, Calderon EJ, CarbonellC, Castano L, Castelao JE, Conde-Vicente R, Cordero-Lorenzana ML, Cortes-SanchezJL, Corton M, Darnaude MT, De Martino-Rodriguez A, Del Campo-Perez V, et al.; SCOURGE Cohort Group; HOSTAGE Cohort Group;GRA@CE Cohort Group; Guillen-Navarro E, Ayuso C, Gonzalez-Neira A, Riancho JA,Rojas-Martinez A, Flores C, Lapunzina P, Carracedo A. Novel genes and sexdifferences in COVID-19 severity. Hum Mol Genet. 2022 Nov 10;31(22):3789-3806.doi: 10.1093/hmg/ddac132. PubMed PMID: 35708486; PubMed Central PMCID:PMC9652109.

Davina-Nunez C, Perez-Castro S, Martinez-Lamas L, Cabrera-Alvargonzalez JJ,Rey-Cao S, Carballo-Fernandez R, Godoy-Diz M, Lopez-Boveda L, Del Campo-Perez V,Suarez-Luque S, Regueiro-Garcia B. Case report: BA.1 subvariant showing aBA.2-like pattern using a variant-specific PCR assay due to a single pointmutation downstream the spike 69/70 deletion. Virol J. 2022 Oct 27;19(1):168.doi: 10.1186/s12985-022-01883-2. PubMed PMID: 36303187; PubMed Central PMCID:PMC9610356.

Garcia MA, Alba P, Del Campo-Perez V, Roverano S, Quintana RM, Alvarez AP,Graf CE, Pisoni C, Spindler A, Gomez C, Figueredo HM, Papasidero S, Paniego R, dela Vega MC, Civit E, Gonzalez Lucero L, Martire MV, Aguila Maldonado R, Gordon S,Gobbi C, Micelli M, Nieto R, Rausch G, Gongora V, Damico A, Dubinsky D, Orden A,Zacariaz J, Romero J, Pera M, Goni M, Rillo O, Baez R, Arturi V, Gonzalez A,Vivero F, Bedoya ME, Shmid MM, Caputo V, Larroude MS, Dominguez N, Gomez GN,Rodriguez GN, Marin J, Collado V, Jorfen M, Bedran Z, Curti A, Gazzoni MV, SaranoJ, Zelaya M, Sacnun M, Finucci Curi P, Rojas Tessel R, Arias Saavedra M, SattlerME, Machado Escobar MA, Astesana P, Paris U, Virasoro BM, Santa Cruz MJ, AllieviA, Vandale JM, Hojberg NG, Pons-Estel B. Multicenter lupus register fromArgentina, the RELESSAR database: Influence of ethnicity on disease phenotype.Lupus. 2022 Apr;31(5):637-645. doi: 10.1177/09612033221083267. PubMed PMID:35382633.

Garcia-Beloso N, Altabas-Gonzalez I, Samartin-Ucha M, Gayoso-Rey M, DeCastro-Parga ML, Salgado-Barreira A, Cibeira-Badia A, Pineiro-Corrales MG,Gonzalez-Vilas D, Pego-Reigosa JM, Martinez-Lopez de Castro N. Switching betweenreference adalimumab and biosimilars in chronic immune-mediated inflammatorydiseases: A systematic literature review. Br J Clin Pharmacol. 2022Feb;88(4):1529-1550. doi: 10.1111/bcp.15101. Epub 2021 Nov 2. PubMed PMID:34622969.
Enlace

Igea A, Carvalheiro T, Malvar-Fernandez B, Martinez-Ramos S, Rafael-Vidal C,Niemantsverdriet E, Varade J, Fernandez-Carrera A, Jimenez N, McGarry T,Rodriguez-Trillo A, Veale D, Fearon U, Conde C, Pego-Reigosa JM,Gonzalez-Fernandez A, Reedquist KA, Radstake TRDJ, van der Helm-Van Mil A, GarciaS. Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and ReducedLevels in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2022Jun;74(6):972-983. doi: 10.1002/art.42065. Epub 2022 Apr 13. PubMed PMID:35001548; PubMed Central PMCID: PMC9322571.
Enlace

Lago-Rivero N, Otero-Millan L, Castro-Nunez I, Mantinan-Gil B, Simon-Valero D,Rey-Gomez Serranillos I, Pena-Gonzalez E, Martinez-Lopez De Castro N.Telemedicine informatics application for nutritional support surveillance ofinstutionalized persons in nursing homes from a hospital pharmacy service. FarmHosp. 2022 Oct 30;46(7):31-35. PubMed PMID: 36520558.

Martin-Lopez M, Galindo M, Pego-Reigosa JM, Jimenez N, Olive Marques A, TomeroE, Freire M, Martinez-Barrio J, Boteanu A, Salgado-Perez E, Fernandez-Nebro A,Calvo J, Menor-Almagro R, Rua-Figueroa I. Clinical characteristics and riskfactors associated with lymphoma in patients with systemic lupus erythematosus: anationwide cohort study. Rheumatology (Oxford). 2022 Dec 23;62(1):217-224. doi:10.1093/rheumatology/keac258. PubMed PMID: 35482477.

Martinez Lamas L, Diz Dios P, Perez Rodriguez MT, Del Campo Perez V, CabreraAlvargonzalez JJ, Lopez Dominguez AM, Fernandez Feijoo J, Diniz Freitas M,Limeres Posse J. Is povidone iodine mouthwash effective against SARS-CoV-2? Firstin vivo tests. Oral Dis. 2022 Apr;28 Suppl 1(Suppl 1):908-911. doi:10.1111/odi.13526. Epub 2020 Jul 29. No abstract available. PubMed PMID:32615642; PubMed Central PMCID: PMC7362147.
Enlace

Martinez-Ramos S, Rafael-Vidal C, Pego-Reigosa JM, Garcia S. Monocytes andMacrophages in Spondyloarthritis: Functional Roles and Effects of CurrentTherapies. Cells. 2022 Feb 2;11(3):515. doi: 10.3390/cells11030515. PubMed PMID:35159323; PubMed Central PMCID: PMC8834543.
Enlace

Pego-Reigosa JM, Peña-Gil C, Rodríguez-Lorenzo D, Altabás-González I, Pérez-Gómez N, Guzmán-Castro JH, Varela-Gestoso R, Díaz-Lambarri R, González-Carreró-López A, Míguez-Senra O, Bóveda-Fontán J, Charle-Crespo Á, Caramés-Casal FJ, Barbazán-Álvarez C, Hernández-Rodríguez Í, Maceiras-Pan F, Rodríguez-López M, Melero-González R, Rodríguez-Fernández JB. Analysis of the implementation of an innovative IT solution to improve waiting times, communication with primary care and efficiency in Rheumatology. BMC Health Serv Res. 2022 Jan;22(1):60. PMID: 35022061. DOI: 10.1186/s12913-021-07455-4. http://www.ncbi.nlm.nih.gov/pubmed/35022061
Enlace

Pluma A, Alsina L, Baniandres O, Caliz R, Casellas M, Grados D, Martinez LopezJA, Perez EP, Polo A, Pego Reigosa JM, Trujillo E, Vela P. Multidisciplinarymodels for pregnancy care in patients with rheumatic diseases: Clinicalexperiences and experts opinion. Eur J Rheumatol. 2022 Oct;9(4):191-196. doi:10.5152/eujrheum.2022.20012. PubMed PMID: 35156620.

Rua-Figueroa I, Rua-Figueroa D, Perez-Veiga N, Anzola AM, Galindo-Izquierdo M,Calvo-Alen J, Fernandez-Nebro A, Sanguesa C, Menor-Almagro R, Tomero E, Del ValN, Uriarte-Isazelaya E, Blanco R, Andreu JL, Boteanu A, Narvaez J, Cobo T,Bohorquez C, Montilla C, Salas E, Toyos FJ, Bernal JA, Salgado E, Freire M, MasAJ, Exposito L, Hernandez-Beriain JA, Ibarguengoitia O, Velloso-Feijoo ML,Lozano-Rivas N, Bonilla G, Moreno M, Jimenez I, Quevedo-Vila V, Pecondon A,Aurrecoechea E, Valls E, Mourino C, Vazquez-Rodriguez T, Pego-Reigosa JM.Antimalarials exert a cardioprotective effect in lupus patients: Insights fromthe Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factorsassociated with heart failure. Semin Arthritis Rheum. 2022 Feb;52:151946. doi:10.1016/j.semarthrit.2021.11.012. Epub 2022 Jan 2. PubMed PMID: 35033377; PubMedCentral PMCID: PMC8720299.
Enlace

Silva-Díaz M, Blanco FJ, Quevedo Vila V, Seoane-Mato D, Pérez-Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis N, Cortés R, Romero Pérez A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, Prado-Galbarro FJ, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S, Working Group Proyecto EPISER2016. Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables. Rheumatol Int. 2022 Jun;42(6):1085–96. PMID: 34755205. DOI: 10.1007/s00296-021-05038-4. http://www.ncbi.nlm.nih.gov/pubmed/34755205
Enlace

Velicia Penas C, Del Campo Perez VM, Rivero Calle I, Armenteros Del Olmo L,Perez Rodriguez MT, Gestal Otero JJ. [Expert opinion on strategies to improvevaccination coverage against seasonal influenza]. Rev Esp Quimioter. 2022Oct;35(5):435-443. doi: 10.37201/req/031.2022. Epub 2022 Jun 21. Spanish. PubMedPMID: 35726347; PubMed Central PMCID: PMC9548073.

Álvaro Gracia JM, Sanchez-Piedra C, Manero J, Ruiz-Lucea ME, López-Vives L, Bohorquez C, Martinez-Barrio J, Bonilla G, Vela P, García-Villanueva MJ, Navío-Marco MT, Pavía M, Galindo M, Erausquin C, Gonzalez-Gay MA, Rua-Figueroa I, Pego-Reigosa JM, Castrejon I, Sanchez-Costa JT, González-Dávila E, Diaz-Gonzalez F, COVIDSER study group. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study. RMD open. 2021;7(3):e001925. PMID: 34887346. DOI: 10.1136/rmdopen-2021-001925. http://www.ncbi.nlm.nih.gov/pubmed/34887346
Enlace

Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Schmajuk G, Tani C, Tedeschi SK, Touma Z, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Costenbader K, Johnson SR. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis. 2021 Jun;80(6):775–81. PMID: 33568386. DOI: 10.1136/annrheumdis-2020-219373. http://www.ncbi.nlm.nih.gov/pubmed/33568386
Enlace

Blanco FJ, Silva-Díaz M, Quevedo Vila V, Seoane-Mato D, Pérez Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis N, Cortés R, Romero Pérez A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S, EPISER2016 Project Working Group. Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study. Reumatol Clin. 2021 Oct;17(8):461–70. PMID: 34625149. DOI: 10.1016/j.reumae.2020.01.005. http://www.ncbi.nlm.nih.gov/pubmed/32360025
Enlace

Blanco-Perez JJ, Arnalich-Montiel V, Salgado-Barreira A, Alvarez-Moure MA,Caldera-Diaz AC, Melero-Gonzalez R, Pallares-Sanmartin A, Fernandez-Villar A,Gonzalez-Barcala FJ. Prevalence and clinical impact of systemic autoimmunerheumatic disease in patients with silicosis. Arch Bronconeumol. 2021Sep;57(9):571-576. doi: 10.1016/j.arbr.2021.06.003. Epub 2021 Jul 17. PubMedPMID: 35702913.
Enlace

Blanco-Perez JJ, Blanco-Dorado S, Rodriguez-Garcia J, Gonzalez-Bello ME,Salgado-Barreira A, Caldera-Diaz AC, Pallares-Sanmartin A, Fernandez-Villar A,Gonzalez-Barcala FJ. Serum levels of inflammatory mediators as prognosticbiomarker in silica exposed workers. Sci Rep. 2021 Jun 25;11(1):13348. doi:10.1038/s41598-021-92587-0. PubMed PMID: 34172787; PubMed Central PMCID:PMC8233419.
Enlace

Cordero OJ, Rafael-Vidal C, Varela-Calviño R, Calviño-Sampedro C, Malvar-Fernández B, García S, Viñuela JE, Pego-Reigosa JM. Distinctive CD26 Expression on CD4 T-Cell Subsets. Biomolecules. 2021;11(10):1446. PMID: 34680079. DOI: 10.3390/biom11101446. http://www.ncbi.nlm.nih.gov/pubmed/34680079
Enlace

Martínez-López-de-Castro N, Álvarez-Payero M, Samartín-Ucha M, Martínez-Reglero C, Martín-Vila A, Rodríguez-Rodríguez M, Piñeiro-Corrales G, Maceiras-Pan JF, Melero-González RB, Pego-Reigosa JM. Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world data study. Clin Exp Rheumatol. 2021 Sep;39(4):736–45. PMID: 32896255. https://pubmed.ncbi.nlm.nih.gov/32896255/
Enlace

Martínez-López-de-Castro N, Samartín-Ucha M, Paradela-Carreiro A, Pérez-Landeiro A, Inaraja-Bobo MT, Álvarez-Payero M, Castro-Núñez I, García-Beloso N, Robles-Torres D, López-López A, González-Costas S, Leboreiro-Enríquez B, Otero-Millán L, Yaiza Romero-Ventosa E, Casanova-Martínez C, Lorenzo-Lorenzo K, Regueira-Arcay AM, Vázquez-López C, Martínez-Reglero C, Piñeiro-Corrales G. Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments. J Clin Pharm Ther. 2021 Jun;46(3):724–30. PMID: 33368439. DOI: 10.1111/jcpt.13337. http://www.ncbi.nlm.nih.gov/pubmed/33368439
Enlace

Mucke J, Alarcon-Riquelme M, Andersen J, Aringer M, Bombardieri S, Brinks R, Cervera R, Chehab G, Cornet A, Costedoat-Chalumeau N, Czirják L, Doria A, Fischer-Betz R, Furie RA, Gatto M, Houssiau FA, Ines L, Liang MH, Morand E, Mosca M, Pego-Reigosa JM, Rúa-Figueroa I, Ruiz-Irastorza G, Terrier B, Voss A, Schneider M. What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts. Lupus Sci Med. 2021;8(1):e000506. PMID: 34016719. DOI: 10.1136/lupus-2021-000506. http://www.ncbi.nlm.nih.gov/pubmed/34016719
Enlace

Pego-Reigosa JM, Nicholson L, Pooley N, Langham S, Embleton N, Marjenberg Z, Barut V, Desta B, Wang X, Langham J, Hammond ER. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology (Oxford). 2021 Oct;60(1):60–72. PMID: 33099651. DOI: 10.1093/rheumatology/keaa478. http://www.ncbi.nlm.nih.gov/pubmed/33099651
Enlace

Pego-Reigosa JM, Restrepo Vélez J, Baldini C, Rúa-Figueroa Fernández de Larrinoa Í. Comorbidities (excluding lymphoma) in Sjögren’s syndrome. Rheumatology (Oxford). 2021 Feb;60(5):2075–84. PMID: 30770715. DOI: 10.1093/rheumatology/key329. http://www.ncbi.nlm.nih.gov/pubmed/30770715
Enlace

Prieto-Peña D, Bernabeu P, Vela P, Narváez J, Fernández-López JC, Freire-González M, González-Álvarez B, Solans-Laqué R, Callejas Rubio JL, Ortego N, Fernández-Díaz C, Rubio E, García-Morillo S, Minguez M, Fernández-Carballido C, de Miguel E, Melchor S, Salgado E, Bravo B, Romero-Yuste S, Salvatierra J, Hidalgo C, Manrique S, Romero-Gómez C, Moya P, Álvarez-Rivas N, Mendizabal J, Ortiz-Sanjuán F, Pérez de Pedro I, Alonso-Valdivielso JL, Perez-Sanchez L, Roldán R, Fernandez-Llanio N, Gómez de la Torre R, Suarez S, Montesa Cabrera MJ, Delgado Sánchez M, Loricera J, Atienza-Mateo B, Castañeda S, González-Gay MA, Blanco R. Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review. Ther Adv Musculoskelet Dis. 2021;13:1759720X211020917. PMID: 34211589. DOI: 10.1177/1759720X211020917. http://www.ncbi.nlm.nih.gov/pubmed/34211589
Enlace

Rafael-Vidal C, Altabás I, Pérez N, Mourino Rodríguez C, Pego-Reigosa JM, Garcia S. Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis. Int J Mol Sci. 2021 Jan;22(3) PMID: 33514066. DOI: 10.3390/ijms22031263. http://www.ncbi.nlm.nih.gov/pubmed/33514066
Enlace

Riveros Frutos A, Holgado S, Sanvisens Bergé A, Casas I, Olivé A, López-Longo FJ, Calvo-Alén J, Galindo M, Fernández-Nebro A, Pego-Reigosa JM, Rúa-Figueroa I, RELESSER Group. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER). Rheumatology (Oxford). 2021 Oct;60(4):1793–803. PMID: 33106841. DOI: 10.1093/rheumatology/keaa477. http://www.ncbi.nlm.nih.gov/pubmed/33106841
Enlace

Rúa-Figueroa Fernández de Larrinoa Í, Carreira PE, Brito García N, Díaz Del Campo Fontecha P, Pego Reigosa JM, Gómez Puerta JA, Ortega-Castro R, Tejera Segura B, Aguado García JM, Torre-Cisneros J, Valencia-Martín JL, Pereda CA, Nishishinya-Aquino MB, Otón Sánchez MT, Silva Fernández L, Maese Manzano J, Chamizo Carmona E, Correyero Plaza M. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases. Reumatol Clin. 2021 Jun;(E-PUB) PMID: 34176767. DOI: 10.1016/j.reuma.2021.04.006. http://www.ncbi.nlm.nih.gov/pubmed/34176767
Enlace

Rúa-Figueroa Fernández de Larrinoa I, Pego-Reigosa JM, en representación de los investigadores del proyecto RELESSER y del grupo EAS-SER, Investigadores del registro RELESSER en su fase transversal. Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain. Reumatol Clin. 2021 May;17(5):245–9. PMID: 32205082. DOI: 10.1016/j.reuma.2020.01.006. http://www.ncbi.nlm.nih.gov/pubmed/32205082
Enlace

Samartín-Ucha M, Pego-Reigosa JM, Álvarez-Payero M, Martin-Vila A, Pineiro-Corrales G, Rodriguez-Rodriguez M, Melero-Gonzalez RB, Maceiras-Pan F, Martinez-Reglero C, Mrtinez-Lopez de Castro N. Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study. Eur J Hosp Pharm Sci Pract. 2021 Nov;28(Suppl 2):e47–50. PMID: 32404382. DOI: 10.1136/ejhpharm-2019-002133. http://www.ncbi.nlm.nih.gov/pubmed/32404382
Enlace

Tejera Segura B, Altabás González I, Rúa-Figueroa I, Pérez Veiga N, Del Campo Pérez V, Olivé-Marqués A, Galindo M, Calvo J, Ovalles-Bonilla JG, Fernández-Nebro A, Menor-Almagro R, Tomero E, Del Val Del Amo N, Uriarte Isacelaya E, Martínez-Taboada VM, Andreu JL, Boteanu A, Narváez J, Movasat A, Montilla C, Senabre Gallego JM, Hernández-Cruz B, Andrés M, Salgado E, Freire M, Machín García S, Moriano C, Expósito L, Pérez Velásquez C, Velloso-Feijoo ML, Cacheda AP, Lozano-Rivas N, Bonilla G, Arévalo M, Jiménez I, Quevedo-Vila V, Manero-Ruiz FJ, García de la Peña Lefebvre P, Vázquez-Rodríguez TR, Ibañez-Rua J, Cobo-Ibañez T, Pego-Reigosa JM. Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know? Rheumatology (Oxford). 2021;60(11):5329–36. PMID: 33950249. DOI: 10.1093/rheumatology/keab401. http://www.ncbi.nlm.nih.gov/pubmed/33950249
Enlace

Verdú RC, Pego-Reigosa JM, Seoane-Mato D, Valle MM, Sánchez DP, Martínez MJM, González MM, Buruaga JAS de, Onaindia IU, Cáceres BAB, Silva-Fernández L, Sivera F, Blanco FJ, Sánchez-Piedra C, Díaz-González F, Bustabad S, Working Group Proyecto EPISER2016. Comment on: Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries? Reply. Rheumatology (Oxford). 2021 Mar;60(3):e120–1. PMID: 33677597. DOI: 10.1093/rheumatology/keaa762. http://www.ncbi.nlm.nih.gov/pubmed/33677597
Enlace

Wienke J, Mertens JS, Garcia S, Lim J, Wijngaarde CA, Yeo JG, Meyer A, van den Hoogen LL, Tekstra J, Hoogendijk JE, Otten HG, Fritsch-Stork RDE, de Jager W, Seyger MMB, Thurlings RM, de Jong EMGJ, van der Kooi AJ, van der Pol WL, Dutch Juvenile Myositis Consortium, Arkachaisri T, Radstake TRDJ, van Royen-Kerkhof A, van Wijk F. Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk. Rheumatology (Oxford). 2021 Aug;60(2):785–801. PMID: 32810267. DOI: 10.1093/rheumatology/keaa270. https://pubmed.ncbi.nlm.nih.gov/32810267/
Enlace

Calderón-Goercke M, Castañeda S, Aldasoro V, Villa I, Prieto-Peña D, Atienza-Mateo B, Patiño E, Moriano C, Romero-Yuste S, Narváez J, Gómez-Arango C, Pérez-Pampín E, Melero R, Becerra-Fernández E, Revenga M, Álvarez-Rivas N, Galisteo C, Sivera F, Olivé-Marqués A, Álvarez Del Buergo M, Marena-Rojas L, Fernández-López C, Navarro F, Raya E, Galindez-Agirregoikoa E, Arca B, Solans-Laqué R, Conesa A, Hidalgo C, Vázquez C, Román-Ivorra JA, Loricera J, Lluch P, Manrique-Arija S, Vela P, De Miguel E, Torres-Martín C, Nieto JC, Ordas-Calvo C, Salgado-Pérez E, Luna-Gomez C, Toyos-Sáenz de Miera FJ, Fernández-Llanio N, García A, Larena C, González-Vela C, Corrales A, Varela-García M, Aurrecoechea E, Dos Santos R, García-Manzanares Á, Ortego N, Fernández S, Ortiz-Sanjuán F, Corteguera M, Hernández JL, González-Gay MÁ, Blanco R. Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice. Clin Exp Rheumatol. 2020;38 Suppl 1(2):112–9. PMID: 32441
Enlace

Calvo-Alén J, Vela P, Bustabad S, Maceiras F, Carmona L, Cea-Calvo L. Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study. Reumatol Clin. 2020 Mar;16(2 Pt 1):116–9. PMID: 29776887. DOI: 10.1016/j.reuma.2018.02.015. http://www.ncbi.nlm.nih.gov/pubmed/29776887
Enlace

Carvalheiro T, Garcia S, Pascoal Ramos MI, Giovannone B, Radstake TRDJ, Marut W, Meyaard L. Leukocyte Associated Immunoglobulin Like Receptor 1 Regulation and Function on Monocytes and Dendritic Cells During Inflammation. Front Immunol. 2020;11(August):1793. PMID: 32973751. DOI: 10.3389/fimmu.2020.01793. http://www.ncbi.nlm.nih.gov/pubmed/32973751
Enlace

Carvalheiro T, Lopes AP, van der Kroef M, Malvar-Fernandez B, Rafael-Vidal C, Hinrichs AC, Servaas NH, Bonte-Mineur F, Kok MR, Beretta L, Zimmermann M, Marut W, Pego-Reigosa JM, Radstake TRDJ, Garcia S. Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients. Int J Mol Sci. 2020 Dec;21(24):9544. PMID: 33333969. DOI: 10.3390/ijms21249544. https://doi.org/10.3390/ijms21249544
Enlace

Carvalheiro T, Malvar Fernández B, Ottria A, Giovannone B, Marut W, Reedquist KA, Garcia S, Radstake TR. Extracellular SPARC cooperates with TGF-? signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts. Rheumatol (United Kingdom). 2020;59(9):2258–63. PMID: 31840182. DOI: 10.1093/rheumatology/kez583. https://pubmed.ncbi.nlm.nih.gov/31840182/
Enlace

Carvalheiro T, Rafael-Vidal C, Malvar-Fernandez B, Lopes AP, Pego-Reigosa JM, Radstake TRDJ, Garcia S. Semaphorin4A-Plexin D1 Axis Induces Th2 and Th17 While Represses Th1 Skewing in an Autocrine Manner. Int J Mol Sci. 2020 Sep;21(18):1–11. PMID: 32971928. DOI: 10.3390/ijms21186965. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555002/pdf/ijms-21-06965.pdf
Enlace

Cobo-Ibáñez T, Urruticoechea-Arana A, Rúa-Figueroa I, Martín-Martínez MA, Ovalles-Bonilla JG, Galindo M, Calvo-Alén J, Olivé A, Fernández-Nebro A, Menor-Almagro R, Tomero E, Horcada L, Uriarte-Itzazelaia E, Martínez-Taboada VM, Andreu JL, Boteanu A, Narváez J, Bohorquez C, Montilla C, Santos G, Hernández-Cruz B, Vela P, Salgado E, Freire M, Hernández-Beriain JÁ, Díez-Álvarez E, Expósito L, Fernández-Berrizbeitia O, Velloso-Feijoo ML, Ibáñez-Barceló M, Lozano-Rivas N, Bonilla G, Moreno M, Raya E, Quevedo-Vila VE, Vázquez-Rodríguez TR, Ibáñez-Ruan J, Muñoz-Fernández S, Sánchez-Alonso F, Pego-Reigosa JM. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2020 Feb;72(2):216–24. PMID: 31529686. DOI: 10.1002/acr.24068. http://www.ncbi.nlm.nih.gov/pubmed/31529686
Enlace

Cortés Verdú R, Pego-Reigosa JM, Seoane-Mato D, Morcillo Valle M, Palma Sánchez D, Moreno Martínez MJ, Mayor González M, Atxotegi Sáenz de Buruaga J, Urionagüena Onaindia I, Blanco Cáceres BA, Silva-Fernández L, Sivera F, Blanco FJ, Sánchez-Piedra C, Díaz-González F, Bustabad S, Working Group Proyecto EPISER2016. Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries? Rheumatology (Oxford). 2020 Sep;59(9):2556–62. PMID: 31998955. DOI: 10.1093/rheumatology/kez668. https://pubmed.ncbi.nlm.nih.gov/31998955/
Enlace

Estévez O, Anibarro L, Garet E, Pallares Á, Pena A, Villaverde C, Del Campo V, González-Fernández Á. Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection. PLoS One. 2020;15(7):e0235859. PMID: 32687494. DOI: 10.1371/journal.pone.0235859. http://www.ncbi.nlm.nih.gov/pubmed/32687494
Enlace

Fernández-Díaz C, Castañeda S, Melero-González RB, Ortiz-Sanjuán F, Juan-Mas A, Carrasco-Cubero C, Casafont-Solé I, Olivé A, Rodríguez-Muguruza S, Almodóvar-González R, Castellanos-Moreira R, Rodríguez-García SC, Aguilera-Cros C, Villa I, Ordóñez-Palau S, Raya-Alvarez E, Morales-Garrido P, Ojeda-García C, Moreno-Ramos MJ, Bonilla Hernán MG, Hernández Rodríguez I, López-Corbeto M, Andreu JL, Jiménez de Aberásturi JRD, Ruibal-Escribano A, Expósito-Molinero R, Pérez-Sandoval T, López-Robles AM, Carreira-Delgado P, Mena-Vázquez N, Urruticoechea-Arana A, Peralta-Ginés C, Arboleya-Rodríguez L, Narváez García FJ, Palma-Sánchez D, Cervantes Pérez EC, Maiz-Alonso O, Alvarez-Rivas MN, Fernández-Melón J, Vela Casasempere P, Cabezas-Rodríguez I, Castellvi-Barranco I, González-Montagut C, Blanco-Madrigal J, Del Val-Del Amo N, Fito MC, Rodríguez-Gómez M, Salgado-Pérez E, García-Magallón B, Hidalgo-Calleja C, López-Sánchez R, Fernández-Aguado S, Fernández-López JC, Castro-Oreiro S, Serrano-García I, García-Valle A, Romero-Y
Enlace

Gómez-Vaquero C, Fábregas-Canales D, Seoane-Mato D, Sánchez-Piedra C, Díaz-González F, Bustabad-Reyes S, en nombre del Grupo de Trabajo del Proyecto EPISER2016, Grupo de Trabajo del Proyecto EPISER2016 (JM Pego). Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study. Med Clin (Barc). 2020 Mar;154(5):163–70. PMID: 31780217. DOI: 10.1016/j.medcli.2019.05.042. https://pubmed.ncbi.nlm.nih.gov/31780217/
Enlace

Hernández Cruz B, Alonso F, Calvo Alén J, Pego-Reigosa JM, López-Longo FJ, Galindo-Izquierdo M, Olivé A, Tomero E, Horcada L, Uriarte E, Erausquin C, Sánchez-Atrio A, Montilla C, Santos Soler G, Fernández-Nebro A, Blanco R, Rodríguez-Gómez M, Vela P, Freire M, Díez-Álvarez E, Boteanu AL, Narváez J, Martínez Taboada V, Ruiz-Lucea E, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Pérez-Venegas JJ, Ibáñez-Barceló M, Pecondón-Español Á, Marras C, Bonilla G, Castellví I, Moreno M, Raya E, Quevedo Vila VE, Vázquez T, Ruán JI, Muñoz S, Rúa-Figueroa Í, RELESSER (Spanish Society of Rheumatology Systemic Lupus Erythematosus register) group. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry). Lupus. 2020 Jan;29(1):27–36. PMID: 31801040. DOI: 10.1177/0961203319889667. https://pubmed.ncbi.nlm.nih.gov/31801040/
Enlace

Johnson SR, Brinks R, Costenbader KH, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger WB, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Aringer M. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Ann Rheum Dis. 2020 Oct;79(10):1333–9. PMID: 32816709. DOI: 10.1136/annrheumdis-2020-217162. http://www.ncbi.nlm.nih.gov/pubmed/3281670
Enlace

Kabala PA, Malvar-Fernández B, Lopes AP, Carvalheiro T, Hartgring SAY, Tang MW, Conde C, Baeten DL, Sleeman M, Tak PP, Connor J, Radstake TR, Reedquist KA, García S. Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients. Rheumatol (United Kingdom). 2020;59(2):426–38. PMID: 31377797. DOI: 10.1093/rheumatology/kez315. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571483/pdf/kez315.pdf
Enlace

Martinez-Lopez-de-Castro N, Alvarez-Payero M, Samartin-Ucha M, Martin-Vila A,Pineiro-Corrales G, Rodriguez-Rodriguez M, Maceiras-Pan FJ, Melero-Gonzalez RB,Pego-Reigosa JM. Biological therapy safety in chronic inflammatory arthropathypatients. Eur J Rheumatol. 2020 Apr;7(2):53-59. doi:10.5152/eurjrheum.2019.19123. Epub 2020 Jan 2. Erratum In: Eur J Rheumatol. 2020Apr;7(2):98. PubMed PMID: 32644925; PubMed Central PMCID: PMC7343225.
Enlace

Mena-Vázquez N, Fernández-Nebro A, Pego-Reigosa JM, Galindo M, Melissa-Anzola A, Uriarte-Isacelay E, Olivé-Marqués A, Aurrecoechea E, Freire M, Tomero E, García-Villanueva MJ, Stoye C, Salas-Heredia E, Bernal-Vidal JA, Salgado E, Blanco R, Javier Novoa F, Ibáñez-Barcelo M, Torrente-Segarra V, Narvaez J, Calvet J, Moriano Morales C, Ramon Vazquez-Rodriguez T, Garcia de la Peña P, Bohórquez C, Andreu-Sánchez JL, Cobo-Ibañez T, Bonilla G, Lozano-Rivas N, Montilla C, Toyos FJ, De la Fuente JLM, Expósito L, Ruiz-Lucea ME, Vals E, Manero-Ruiz J, Bernal-Vidal JA, Rua-Figueroa I. Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry. Rheumatology (Oxford). 2020 Aug;59(8):2043–51. PMID: 31808534. DOI: 10.1093/rheumatology/kez562. https://pubmed.ncbi.nlm.nih.gov/31808534/
Enlace

Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae S-C, Brohawn PZ, Pineda L, Berglind A, Tummala R, TULIP-2 Trial Investigators (JM Pego). Trial of Anifrolumab in Active Systemic Lupus Erythematosus. N Engl J Med. 2020 Jan;382(3):211–21. PMID: 31851795. DOI: 10.1056/NEJMoa1912196. http://www.ncbi.nlm.nih.gov/pubmed/31851795
Enlace

Queiro R, Coto P, Joven B, Rivera R, Navío Marco T, de la Cueva P, Alvarez Vega JL, Narváez Moreno B, Rodriguez Martínez FJ, Pardo Sánchez J, Feced Olmos C, Pujol C, Rodríguez J, Notario J, Pujol Busquets M, García Font M, Galindez E, Pérez Barrio S, Urruticoechea-Arana A, Hergueta M, López Montilla MD, Vélez García-Nieto A, Maceiras F, Rodríguez Pazos L, Rubio Romero E, Rodríguez Fernandez Freire L, Luelmo J, Gratacós J. Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project. Reumatol Clin. 2020 Feb;16(1):24–31. PMID: 29496420. DOI: 10.1016/j.reuma.2018.01.010. http://www.ncbi.nlm.nih.gov/pubmed/29496420
Enlace

Rafael-Vidal C, Pérez N, Altabás I, Garcia S, Pego-Reigosa JM. Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases. Int J Mol Sci. 2020 Sep;21(19):1–14. PMID: 32993066. DOI: 10.3390/ijms21197100. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582977/pdf/ijms-21-07100.pdf
Enlace

Riancho-Zarrabeitia L, Martínez-Taboada V, Rúa-Figueroa I, Alonso F, Galindo-Izquierdo M, Ovalles J, Olivé-Marqués A, Fernández-Nebro A, Calvo-Alén J, Menor-Almagro R, Tomero-Muriel E, Uriarte-Isacelaya E, Botenau A, Andres M, Freire-González M, Santos Soler G, Ruiz-Lucea E, Ibáñez-Barceló M, Castellví I, Galisteo C, Quevedo Vila V, Raya E, Narváez-García J, Expósito L, Hernández-Beriaín JA, Horcada L, Aurrecoechea E, Pego-Reigosa JM. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality. Lupus. 2020 Oct;29(12):1556–65. PMID: 32807021. DOI: 10.1177/0961203320950477. http://www.ncbi.nlm.nih.gov/pubmed/32807021
Enlace

Riancho-Zarrabeitia L, Martínez-Taboada VM, Rúa-Figueroa I, Alonso F, Galindo-Izquierdo M, Ovalles J, Olivé-Marqués A, Mena Vázquez N, Calvo-Alén J, Menor Almagro R, Tomero Muriel E, Uriarte Isacelaya E, Boteanu A, Andres M, Freire González M, Santos Soler G, Ruiz-Lucea ME, Ibáñez-Barceló M, Castellví I, Galisteo C, Quevedo Vila V, Raya E, Narváez J, Expósito L, Hernández Beriaín JA, Horcada L, Aurrecoechea E, Pego Reigosa JM. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients? Clin Exp Rheumatol. 2020;39(3):555–63. PMID: 32828148. http://www.ncbi.nlm.nih.gov/pubmed/32828148
Enlace

Rúa-Figueroa I, López-Longo FJ, Del Campo V, Galindo-Izquierdo M, Uriarte E, Torre-Cisneros J, Vela P, Tomero E, Narváez J, Olivé A, Freire M, Salgado E, Andreu JL, Martínez-Taboada V, Calvo-Alén J, Hernández-Cruz B, Raya E, Quevedo V, Expósito Pérez L, Fernández-Nebro A, Ibañez M, Pascual-Valls È, Rúa-Figueroa D, Naranjo A, Pego-Reigosa JM. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes. J Rheumatol. 2020 Feb;47(2):234–40. PMID: 30988123. DOI: 10.3899/jrheum.180882. https://pubmed.ncbi.nlm.nih.gov/30988123/
Enlace

Salman-Monte TC, Sanchez-Piedra C, Fernandez Castro M, Andreu JL, Martinez Taboada V, Olivé A, Rosas J, Menor R, Rodríguez B, Garcia Aparicio A, Lopez Longo FJ, Manrique-Arija S, Garcia Vadillo JA, Gil Barato S, López-González R, Galisteo C, Gonzalez Martin J, Ruiz Lucea E, Erausquin C, Melchor S, Moreira B, Raya E, Pego-Reigosa JM, Cid N, Júdez E, Moriano C, Narváez FJ, Corominas H, Garcia Magallon B, Guillen Astete C, Castellvi I, Bohórquez C, Loricera J, Belzunegui J, Illera Ó, Torrente-Segarra V. Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome. Rheumatol Int. 2020 Aug;40(8):1259–65. PMID: 32533289. DOI: 10.1007/s00296-020-04615-3. http://www.ncbi.nlm.nih.gov/pubmed/32533289
Enlace

Sanchez-Piedra C, Diaz-Torne C, Manero J, Pego-Reigosa JM, Rúa-Figueroa Í, Gonzalez-Gay MA, Gomez-Reino J, Alvaro-Gracia JM, BIOBADASER study group. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies. Ann Rheum Dis. 2020;79(7):988–90. PMID: 32503857. DOI: 10.1136/annrheumdis-2020-217948. http://www.ncbi.nlm.nih.gov/pubmed/32503857
Enlace

Torrente-Segarra V, Salman-Monte TC, Rúa-Figueroa Í, Del Campo V, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Mouriño-Rodríguez C, Horcada L, Bohórquez C, Montilla C, Salgado E, Díez-Álvarez E, Blanco R, Andreu JL, Fernández-Berrizbeitia O, Expósito L, Gantes M, Hernández-Cruz B, Pecondón-Español Á, Lozano-Rivas N, Bonilla G, Lois Iglesias A, Rubio-Muñoz P, Ovalles J, Tomero E, Boteanu A, Narvaez J, Freire M, Vela P, Quevedo-Vila V, Juan Mas A, Muñoz-Fernández S, Raya E, Moreno M, Velloso-Feijoo ML, Soler G, Vázquez-Rodríguez TR, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER). Semin Arthritis Rheum. 2020 May;50(4):657–62. PMID: 32505871. DOI: 10.1016/j.semarthrit.2020.05.016. http://www.ncbi.nlm.nih.gov/pubmed/32505871
Enlace

Urruticoechea-Arana A, León-Vázquez F, Giner-Ruiz V, Andréu-Sánchez JL, Olivé-Marqués A, Freire-González M, Pego-Reigosa JM, Muñoz-Fernández S, Román-Ivorra JA, Alegre-Sancho JJ, Vargas-Negrín F, Medina-Abellán M, Cobo-Ibáñez T, Mas-Garriga X, Calvo-Alén J, Costa-Ribas C, Blanco-Vela R, Pérez-Martín Á, Beltrán-Catalán E, Forcada-Gisbert J, Hernández-Miguel MV, Hermosa-Hernán JC, Narváez-García J, Nieto-Pol E, Rúa-Figueroa Í. Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology. Reumatol Clin. 2020 Sep;16(5 Pt 2):373–7. PMID: 31722849. DOI: 10.1016/j.reuma.2019.09.001. https://pubmed.ncbi.nlm.nih.gov/31722849/
Enlace

Altabás-González I, Pérez-Gómez N, Pego-Reigosa JM. How to investigate: Suspected systemic rheumatic diseases in patients presenting with muscle complaints. Best Pract Res Clin Rheumatol. 2019 Aug;33(4):101437. PMID: 31810549. DOI: 10.1016/j.berh.2019.101437. http://www.ncbi.nlm.nih.gov/pubmed/31810549
Enlace

Amado-Puentes A, Reparaz-Andrade A, Del Campo-Garcia A, Blanco-Barca MO,Salgado-Barreira A, Del Campo-Perez V, Fernandez-Lorenzo JR. NeurodevelopmentalDisorders and Array-Based Comparative Genomic Hybridization: Sensitivity andSpecificity using a Criteria Checklist for Genetic Test Performance.Neuropediatrics. 2019 Jun;50(3):164-169. doi: 10.1055/s-0039-1685216. Epub 2019Apr 2. PubMed PMID: 30939599.

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019 Jun;78(9):1151–9. PMID: 31383717. DOI: 10.1136/annrheumdis-2018-214819. https://pubmed.ncbi.nlm.nih.gov/31383717/
Enlace

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey?Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat?Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz?Irastorza G, Sanchez?Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda?Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego?Reigosa JM, Romero?Diaz J, Rúa?Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 Sep;71(9):1400–12. PMID: 31385462. DOI: 10.1002/art.40930. https://pubmed.ncbi.nlm.nih.gov/31385462/
Enlace

Blanco Perez JJ, Arnalich Montiel V, Salgado-Barreira A, Alvarez Moure MA,Caldera Diaz AC, Cerdeira Dominguez L, Gonzalez Bello ME, Fernandez Villar A,Gonzalez Barcala FJ. The 6-Minute Walk Test as a Tool for Determining ExerciseCapacity and Prognosis in Patients with Silicosis. Arch Bronconeumol (Engl Ed).2019 Feb;55(2):88-92. doi: 10.1016/j.arbres.2018.07.004. Epub 2018 Aug 9.English, Spanish. PubMed PMID: 30100206.

López V, Castro ML De, Ucha S, Meléndez F. Evaluación de la satisfacción global de los pacientes con nutrición enteral domiciliaria en la consulta de farmacia hospitalaria?: estudio. Rev Nutr Clin y Diet Hosp. 2019;39(3):146–53. DOI: 10.12873/393vazquez. https://runa.sergas.es/xmlui/handle/20.500.11940/12681
Enlace

Martinez-Lopez de Castro N, Alvarez-Payero M, Samartin-Ucha M, Martin-Vila A,Pineiro-Corrales G, Pego Reigosa JM; Working Group IRIDIS (Rheumatology,Immunology and Immune-Mediated Diseases); Rodriguez-Rodriguez M, Melero-GonzalezRB, Maceiras-Pan FJ. Adherence to biological therapies in patients with chronicinflammatory arthropathies. Farm Hosp. 2019 Jul 1;43(4):134-139. doi:10.7399/fh.11183. PubMed PMID: 31276446.
Enlace

Martínez-López De Castro N, Samartín-Ucha M, Martín-Vila A, Álvarez-Payero M, Piñeiro-Corrales G, Pego-Reigosa JM. Content analysis of Twitter in relation to biological treatments for chronic inflammatory arthropathies: an exploratory study. Eur J Hosp Pharm Sci Pract. 2019 May;26(3):124–8. PMID: 31428318. DOI: 10.1136/ejhpharm-2017-001402. http://www.ncbi.nlm.nih.gov/pubmed/31428318
Enlace

Rosas J, Sánchez-Piedra C, Fernández-Castro M, Andreu JL, Martínez-Taboada V, Olivé A, SJÖGRENSER Group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group-EASSER (Marina Rodríguez López; Coral Mouriño; JMP. ESSDAI activity index of the SJÖGRENSER cohort: analysis and comparison with other European cohorts. Rheumatol Int. 2019 Jun;39(6):991–9. PMID: 30891620. DOI: 10.1007/s00296-019-04285-w. http://www.ncbi.nlm.nih.gov/pubmed/30891620
Enlace

Samartín-Ucha M, Castro-Domínguez J, Fernández-Vega H, Piñeiro-Corrales G, Coordinating Group on Safety in High-Alert-Medication in Xerencia de Xestión Integrada de Vigo VS (Noemí M-L-CAP-C. Devising of a risk map on the management of high risk alert medication in a high level university hospital. Farm Hosp. 2019;43(3):110–5. PMID: 31072289. DOI: 10.7399/fh.11175. http://www.ncbi.nlm.nih.gov/pubmed/31072289
Enlace

Samartín-Ucha M, Piñeiro-Corrales G, Continuity of Care Group from the EOXI Vigo. Model of teleconsultation pharmaceutical integrated in the electronic clinical history of the patient. Farm Hosp. 2019;43(1):1–5. PMID: 30624166. DOI: 10.7399/fh.10937. http://www.ncbi.nlm.nih.gov/pubmed/30624166
Enlace

Seoane-Mato D, Sánchez-Piedra C, Silva-Fernández L, Sivera F, Blanco FJ, Pérez Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis Martí N, Cortés Verdú R, Antón-Pagés F, Quevedo Vila V, Garrido Courel L, Del Amo NDV, Paniagua Zudaire I, Añez Sturchio G, Medina Varo F, Ruiz Tudela MDM, Romero Pérez A, Ballina J, Brandy García A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, González Álvarez B, Casas Hernández L, Álvarez Reyes F, Delgado Sánchez M, Martínez Dubois C, Sánchez-Fernández SÁ, Rojas Vargas LM, García Morales PV, Olivé A, Rubio Muñoz P, Larrosa M, Navarro Ricos N, Graell Martín E, Chamizo E, Chaves Chaparro L, Rojas Herrera S, Pons Dolset J, Polo Ostariz MÁ, Ruiz-Alejos Garrido S, Macía Villa C, Cruz Valenciano A, González Gómez ML, Morcillo Valle M, Palma Sánchez D, Moreno Martínez MJ, Mayor González M, Atxotegi Sáenz de Buruaga J, Urionagüena Onaindia I, Blanco Cáceres BA, Díaz-González F, Bustabad S. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims an
Enlace

Silva-Fernández L, Otón T, Askanase A, Carreira P, López-Longo FJ, Olivé A, Rúa-Figueroa Í, Narváez J, Ruiz-Lucea E, Andrés M, Calvo E, Toyos F, Alegre-Sancho JJ, Tomero E, Montilla C, Zea A, Uriarte E, Calvo-Alén J, Marras C, Martínez-Taboada VM, Belmonte-López MÁ, Rosas J, Raya E, Bonilla G, Freire M, Pego-Reigosa JM, Millán I, Hughes-Morley A, Andreu JL, from the Spanish Society for Rheumatology Systemic Autoimmune Diseases Study Group (EAS-SER). Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature. Reumatol Clin. 2019 May;15(1):34–42. PMID: 28528869. DOI: 10.1016/j.reuma.2017.04.005. http://www.ncbi.nlm.nih.gov/pubmed/28528869
Enlace

Tejera Segura B, Rua-Figueroa I, Pego-Reigosa JM, Del Campo V, Wincup C, Isenberg D, Rahman A. Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort. BMJ Open. 2019;9(6):1–9. PMID: 31203250. DOI: 10.1136/bmjopen-2018-028697. https://pubmed.ncbi.nlm.nih.gov/31203250/
Enlace

Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, De Uña-Álvarez J, Balboa-Barreiro V, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Mouriño-Rodríguez C, Horcada L, Sánchez-Atrio A, Montilla C, Salgado E, Díez-Álvarez E, Blanco R, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JA, Gantes M, Hernández-Cruz B, Pecondón-Español A, Marras C, Bonilla G, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Semin Arthritis Rheum. 2019 Sep;48(6):1025–9. PMID: 30344081. DOI: 10.1016/j.semarthrit.2018.09.005. http://www.ncbi.nlm.nih.gov/pubmed/30344081
Enlace

Julià A, López-Longo FJ, Pérez Venegas JJ, Bonàs-Guarch S, Olivé À, Andreu JL, Aguirre-Zamorano MÁ, Vela P, Nolla JM, de la Fuente JLM, Zea A, Pego-Reigosa JM, Freire M, Díez E, Rodríguez-Almaraz E, Carreira P, Blanco R, Taboada VM, López-Lasanta M, Corbeto ML, Mercader JM, Torrents D, Absher D, Marsal S, Fernández-Nebro A. Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus. Arthritis Res Ther. Arthritis Research & Therapy; 2018 May;20(1):100. PMID: 29848360. DOI: 10.1186/s13075-018-1604-1. http://www.ncbi.nlm.nih.gov/pubmed/29848360
Enlace

Martinez-Lopez de Castro N, Matilla-Fernandez MB, Fraga-Fuentes MD,Mangues-Bafalluy I, Asensi-Diez R, Cajaraville-Ordonana G. Spanish Society ofHospital Pharmacy position paper on biosimilar medicines. Farm Hosp. 2018 Jul1;42(4):180-183. doi: 10.7399/fh.10973. PubMed PMID: 29959844.
Enlace

Martínez-López-de-Castro N, Álvarez-Payero M, Martín-Vila A, Samartín-Ucha M, Iglesias-Neiro P, Gayoso-Rey M, Feijoo-Meléndez D, Casanova-Martínez C, Fariña-Conde M, Piñeiro-Corrales G. Factors associated with patient satisfaction in an outpatient hospital pharmacy. Eur J Hosp Pharm. 2018 Jul;25(4):183–8. DOI: 10.1136/ejhpharm-2016-001192. http://ejhp.bmj.com/lookup/doi/10.1136/ejhpharm-2016-001192
Enlace

Narváez J, Borrell H, Sánchez-Alonso F, Rúa-Figueroa I, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Fernández-Nebro A, Olivé A, Andreu JL, Martínez-Taboada V, Nolla JM, Pego-Reigosa JM, RELESSER Study Group. Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort. Arthritis Res Ther. Arthritis Research & Therapy; 2018;20(1):280. PMID: 30567600. DOI: 10.1186/s13075-018-1776-8. http://www.ncbi.nlm.nih.gov/pubmed/30567600
Enlace

Romero-Ventosa EY, Gayoso-Rey M, Samartín-Ucha M, Lamas-Domínguez P, Rubianes-González M, Rodríguez-Lorenzo D, Rodríguez-Vázquez MH, García-Comesaña J, Piñeiro-Corrales G. Pharmacotherapeutic Reports as Tools for Detecting Discrepancies in Continuity of Care. Ther Innov Regul Sci. 2018 Jan;52(1):94–9. PMID: 29714617. DOI: 10.1177/2168479017716716. http://www.ncbi.nlm.nih.gov/pubmed/29714617
Enlace

Álvarez-Payero M, Valeiras-Muñoz C, Lion-Vázquez S, Piñeiro-Corrales G, Muñoz-García D, Midaglia L. Experience with fampridine in clinical practice: analysis of a possible marker of clinical response. Int J Neurosci. 2017 Oct;127(10):915–22. PMID: 28054826. DOI: 10.1080/00207454.2017.1279614. IF2017: 1.848; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28054826
Enlace

Blanco-Pérez JJ, Arnalich Montiel V, Guerra Vales JL. Plastic bronchitis in a patient with silicosis. Arch Bronconeumol. 2017 Sep;53(9):516. PMID: 28365186. DOI: 10.1016/j.arbres.2017.02.012. IF2017: 2.633; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28365186
Enlace

Cabrerizo M, García-Iñiguez JP, Munell F, Amado A, Madurga-Revilla P, Rodrigo C, Pérez S, Martínez-Sapiña A, Antón A, Suárez G, Rabella N, Del Campo V, Otero A, Masa-Calles J. First Cases of Severe Flaccid Paralysis Associated With Enterovirus D68 Infection in Spain, 2015-2016. Pediatr Infect Dis J. 2017 Dec;36(12):1214–6. PMID: 28661963. DOI: 10.1097/INF.0000000000001668. IF2017: 2.305; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28661963
Enlace

Calvo-Alén J, Monteagudo I, Salvador G, Vázquez-Rodríguez TR, Tovar-Beltrán J V, Vela P, Maceiras F, Bustabad S, Román-Ivorra JA, Díaz-Miguel C, Rosas J, Raya E, Carmona L, Cea-Calvo L, Arteaga MJ, Fernández S, Marras C. Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study. Clin Exp Rheumatol. 2017 May;35(3):423–30. PMID: 28032846. IF2017: 3.201; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28032846
Enlace

Clowse MEB, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczy?ski P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C, EMBODY Investigator Group ( JM Pego-Reigosa). Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials. Arthritis Rheumatol (Hoboken, NJ). 2017 Feb;69(2):362–75. PMID: 27598855. DOI: 10.1002/art.39856. IF2017: 7.871; D1. http://www.ncbi.nlm.nih.gov/pubmed/27598855
Enlace

Cordero OJ, Varela-Calviño R, López-González T, Grujic M, Juranic Z, Mouriño C, Hernández-Rodríguez Í, Rodríguez-López M, de la Iglesia BA, Pego-Reigosa JM. Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest. Clin Biochem. 2017 Nov;50(16–17):903–10. PMID: 28599787. DOI: 10.1016/j.clinbiochem.2017.06.001. IF2017: 2.584; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28599787
Enlace

de Castro ML, Sanromán L, Martín A, Figueira M, Martínez N, Hernández V, Del Campo V, Pineda JR, Martínez-Cadilla J, Pereira S, Rodríguez Prada JI. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index. Rev Esp Enferm Dig. 2017 Aug;109(8):542–51. PMID: 28679280. DOI: 10.17235/reed.2017.5137/2017. IF2017: 1.632; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28679280
Enlace

López LC, De Benito Basanta L, Bustelo MS, Corral AB, Lorenzo JRF. Enfermedad de Vogt-Koyanagi-Harada: Una causa rara de uveítis. Acta Pediatr Esp. 2017 Jul;75(7–8):e141–3. IF2017: N/A. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034649037&partnerID=40&md5=662f74a7d64b62dd8a347eacde728846
Enlace

Martínez López JA, García Vivar ML, Cáliz R, Freire M, Galindo M, Hernández MV, López Longo FJ, Martínez Taboada V, Pego Reigosa JM, Rubio E, Trujillo E, Vela-Casasempere P. Recommendations for the evaluation and management of patients with rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy, postpartum and breastfeeding. Reumatol Clin. 2017 Sep;13(5):264–81. PMID: 27321859. DOI: 10.1016/j.reuma.2016.05.003. IF2017: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27321859
Enlace

Riveros Frutos A, Casas I, Rúa-Figueroa I, López-Longo FJ, Calvo-Alén J, Galindo M, Fernández-Nebro A, Pego-Reigosa JM, Olivé Marqués A, RELESSER Group part of the SS of RSADSG (EASSER). Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort. Lupus. 2017 Jun;26(7):698–706. PMID: 27799439. DOI: 10.1177/0961203316673728. IF2017: 2.969; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27799439
Enlace

Rúa-Figueroa I, Fernández Castro M, Andreu JL, Sanchez-Piedra C, Martínez-Taboada V, Olivé A, López-Longo J, Rosas J, Galindo M, Calvo-Alén J, Fernández-Nebro A, Alonso F, Rodríguez-Lozano B, Alberto García Vadillo J, Menor R, Narváez FJ, Erausquin C, García-Aparicio Á, Tomero E, Manrique-Arija S, Horcada L, Uriarte E, Gil S, Blanco R, López-González R, Boteanu A, Freire M, Galisteo C, Rodríguez-Gómez M, Díez-Álvarez E, Pego-Reigosa JM, Sjogrenser and Relesser Researchers and EAS-SER Group. Comorbidities in Patients With Primary Sjögren’s Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study. Arthritis Care Res (Hoboken). 2017 Jan;69(1):38–45. PMID: 27564390. DOI: 10.1002/acr.23015. IF2017: 4.149; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27564390
Enlace

Rúa-Figueroa Í, López-Longo J, Galindo-Izquierdo M, Calvo-Alén J, Del Campo V, Olivé-Marqués A, Pérez-Vicente S, Fernández-Nebro A, Andrés M, Erausquin C, Tomero E, Horcada L, Uriarte E, Freire M, Montilla C, Sánchez-Atrio A, Santos G, Boteanu A, Díez-Álvarez E, Narváez J, Martínez-Taboada V, Silva-Fernández L, Ruiz-Lucea E, Andreu JL, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras C, Ibáñez-Barceló M, Bonilla G, Torrente V, Castellví I, Alegre JJ, Calvet J, Marenco JL, Raya E, Vázquez T, Quevedo V, Muñoz-Fernández S, Rodríguez-Gómez M, Ibáñez J, Pego-Reigosa JM. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2017 Aug;47(1):38–45. PMID: 28259425. DOI: 10.1016/j.semarthrit.2017.01.010. IF2017: 4.365; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28259425
Enlace

Schneider M, Mosca M, Pego-Reigosa J-MM, Gunnarsson I, Maurel F, Garofano A, Perna A, Porcasi R, Devilliers H. Cross-cultural validation of lupus impact tracker in five European clinical practice settings. Rheumatol (United Kingdom). 2017 May;56(5):818–28. PMID: 28204765. DOI: 10.1093/rheumatology/kew492. IF2017: 5.245; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28204765
Enlace

Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, Sánchez-Alonso F, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ibañez-Ruán J, Horcada L, Sánchez-Atrio A, Montilla C, Melero González RB, Díez-Álvarez E, Martinez-Taboada V, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pecondón-Español Á, Marras C, Bonilla G, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Clin Exp Rheumatol. 2017 Jun;35(6):1047–55. PMID: 28628467. IF2017: 3.201; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28628467
Enlace

Alonso A, Julià A, Vinaixa M, Domènech E, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, Gisbert JP, Nos P, Casbas AG, Puig L, González-Álvaro I, Pinto-Tasende JA, Blanco R, Rodríguez MA, Beltran A, Correig X, Marsal S, IMID Consortium. Urine metabolome profiling of immune-mediated inflammatory diseases. BMC Med. BMC Medicine; 2016 Sep;14(1):133. PMID: 27609333. DOI: 10.1186/s12916-016-0681-8. IF2016: 7.901; D1. http://www.ncbi.nlm.nih.gov/pubmed/27609333
Enlace

Blanco-Pérez JJ, Pérez González A, Morano Amado LE, Guerra Vales JL, Vázquez Gallardo R, Salgado Barreira Á, Cruz Carmona MJ, González Barcala FJ. Clinical Significance of Environmental Mycobacteria Isolated From Respiratory Specimens of Patients With and Without Silicosis. Arch Bronconeumol. 2016 Mar;52(3):145–50. PMID: 26304492. DOI: 10.1016/j.arbres.2015.07.007. IF2016: 2.979; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26304492
Enlace

Galindo-Izquierdo M, Rodriguez-Almaraz E, Pego-Reigosa JM, López-Longo FJ, Calvo-Alén J, Olivé A, Fernández-Nebro A, Martinez-Taboada V, Vela-Casasempere P, Freire M, Narváez FJ, Rosas J, Ibáñez-Barceló M, Uriarte E, Tomero E, Zea A, Horcada L, Torrente V, Castellvi I, Calvet J, Menor-Almagro R, Zamorano MAA, Raya E, Díez-Álvarez E, Vázquez-Rodríguez T, García de la Peña P, Movasat A, Andreu JL, Richi P, Marras C, Montilla-Morales C, Hernández-Cruz B, Marenco de la Fuente JL, Gantes M, Úcar E, Alegre-Sancho JJ, Manero J, Ibáñez-Ruán J, Rodríguez-Gómez M, Quevedo V, Hernández-Beriaín J, Silva-Fernández L, Alonso F, Pérez S, Rúa-Figueroa I, RELESSER Group from SS of RSADSG (EASSER). Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER). Medicine (Baltimore). 2016 Mar;95(9):e2891. PMID: 26945378. DOI: 10.1097/MD.0000000000002891. IF2016: 1.804; Q2. http://www.ncbi.nlm.nih.gov/pubmed/
Enlace

Pego-Reigosa JM, Lois-Iglesias A, Rúa-Figueroa Í, Galindo M, Calvo-Alén J, de Uña-Álvarez J, Balboa-Barreiro V, Ibáñez Ruan J, Olivé A, Rodríguez-Gómez M, Fernández Nebro A, Andrés M, Erausquin C, Tomero E, Horcada Rubio L, Uriarte Isacelaya E, Freire M, Montilla C, Sánchez-Atrio AI, Santos-Soler G, Zea A, Díez E, Narváez J, Blanco-Alonso R, Silva-Fernández L, Ruiz-Lucea ME, Fernández-Castro M, Hernández-Beriain JÁ, Gantes-Mora M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras Fernández-Cid C, Ibáñez-Barcelo M, Bonilla G, Torrente-Segarra V, Castellví I, Alegre JJ, Calvet J, Marenco de la Fuente JL, Raya E, Vázquez-Rodríguez TR, Quevedo-Vila V, Muñoz-Fernández S, Otón T, Rahman A, López-Longo FJ. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry. Rheumatology (Oxford). 2016 Jul;55(7):1243–50. PMID: 27018057. DOI: 10.1093/rheumatol
Enlace

Rodríguez Huerta MD, Trujillo-Martín MM, Rúa-Figueroa Í, Cuellar-Pompa L, Quirós-López R, Serrano-Aguilar P, Spanish SLE CPG Development Group (JM Pego-Reigosa; N Martínez López de Castro). Healthy lifestyle habits for patients with systemic lupus erythematosus: A systemic review. Semin Arthritis Rheum. Elsevier; 2016 Feb;45(4):463–70. PMID: 26522137. DOI: 10.1016/j.semarthrit.2015.09.003. IF2016: 4.498; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26522137
Enlace

Romero-Ventosa EY, Samartín-Ucha M, Martín-Vila A, Martínez-Sánchez ML, Rey Gómez-Serranillos I, Pineiro-Corrales G. Multidisciplinary teams involved: detection of drug-related problems through continuity of care. Farm Hosp. 2016 Nov;40(n06):529–43. PMID: 27894227. DOI: 10.7399/fh.2016.40.6.10506. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27894227
Enlace

Schneider M, Mosca M, Pego-Reigosa JM, Hachulla E, Teh L-S, Perna A, Koscielny V, Pike J, Lobosco S, Apolone G. Understanding remission in real-world lupus patients across five European countries. Lupus. 2016 Apr;25(5):505–12. PMID: 26635245. DOI: 10.1177/0961203315619030. IF2016: 2.454; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26635245
Enlace

Torrente-Segarra V, Salman-Monte TC, Rúa-Figueroa Í, Pérez-Vicente S, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ibañez-Ruán J, Horcada L, Sánchez-Atrio A, Montilla C, Rodríguez-Gómez M, Díez-Álvarez E, Martinez-Taboada V, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JA, Gantes M, Hernández-Cruz B, Pecondón-Español Á, Marras C, Bonilla G, Pego-Reigosa JM, RELESSER Study Group of the Spanish Society of Rheumatology (SER), Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2016 Nov;34(2 Suppl 96):S40-7. PMID: 26575317. IF2015: 2.495; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26575317
Enlace

Trujillo-Martín MM, Rúa-Figueroa Fernández de Larrinoa I, Ruíz-Irastorza G, Pego-Reigosa JM, Sabio Sánchez JM, Serrano-Aguilar P, en nombre del Grupo Elaborador de la GPC-LES. [Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management]. Med Clin (Barc). 2016 May;146(9):413.e1-14. PMID: 26975887. DOI: 10.1016/j.medcli.2016.01.013. IF2016: 1.125; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26975887
Enlace

Blanco-Pérez JJ, Pérez González A, Guerra Vales JL, Melero Gonzalez R, Pego Reigosa JM. Shrinking Lung in Primary Sjogrën Syndrome Successfully Treated with Rituximab. Arch Bronconeumol. 2015 Sep;51(9):475–6. PMID: 25582545. DOI: 10.1016/j.arbres.2014.11.016. IF2015: 1.771; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25582545
Enlace

Cordero OJ, Varela-Calviño R, López-González T, Calviño-Sampedro C, Viñuela JE, Mouriño C, Hernández-Rodríguez Í, Rodríguez-López M, Aspe de la Iglesia B, Pego-Reigosa JM, Pego JM. CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis. PLoS One. 2015 Jul;10(7):e0131992. PMID: 26177310. DOI: 10.1371/journal.pone.0131992. IF2015: 3.057; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26177310
Enlace

Fernández Álvarez R, Martínez González C, Quero Martínez A, Blanco-Pérez JJ, Carazo Fernández L, Prieto Fernández A. Guidelines for the diagnosis and monitoring of silicosis. Arch Bronconeumol. 2015 Feb;51(2):86–93. PMID: 25479706. DOI: 10.1016/j.arbres.2014.07.010. IF2015: 1.771; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25479706
Enlace

Fernández-Nebro A, Rúa-Figueroa Í, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ordóñez-Cañizares C, Martín-Martínez MA, Blanco R, Melero-González R, Ibáñez-Rúan J, Bernal-Vidal JA, Tomero-Muriel E, Uriarte-Isacelaya E, Horcada-Rubio L, Freire-González M, Narváez J, Boteanu AL, Santos-Soler G, Andreu JL, Pego-Reigosa JM, EAS-SER (Systemic Diseases Study Group of Spanish Society of Rheumatology). Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry. Medicine (Baltimore). 2015 Jul;94(29):e1183. PMID: 26200625. DOI: 10.1097/MD.0000000000001183. IF2015: 2.133; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26200625
Enlace

Ferraz-Falcao JR, Cadaval-Rodríguez T, Rodríguez-Iglesia RM, del Campo-Pérez VM. [Palliative care needs in the inmobilized population of a Primary Care area in Vigo Spain]. Semergen. 2015 Sep;41(6):305–14. PMID: 25442465. DOI: 10.1016/j.semerg.2014.06.017. IF2015: N/A. http://www.ncbi.nlm.nih.gov/pubmed/25442465
Enlace

García de la Peña Lefebvre P, Nishishinya MB, Pereda CA, Loza E, Sifuentes Giraldo WA, Román Ivorra JA, Carreira P, Rúa-Figueroa I, Pego-Reigosa JM, Muñoz-Fernández S. Efficacy of Raynaud’s phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review. Rheumatol Int. 2015 Sep;35(9):1447–59. PMID: 25824427. DOI: 10.1007/s00296-015-3241-1. IF2015: 1.702; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25824427
Enlace

González Chávez J, Asensi Diez R, Tamayo Bermejo R, Alegre Del Rey EJ, Martínez López de Castro N. [Vedolizumab in Crohn Disease genesis-sefh drug evaluation report]. Farm Hosp. 2015 Sep;39(5):297–308. PMID: 26546942. DOI: 10.7399/fh.2015.39.5.8981. IF2015: N/A. http://www.ncbi.nlm.nih.gov/pubmed/26546942
Enlace

Inês L, Silva C, Galindo M, López-Longo FJ, Terroso G, Romão VC, Rúa-Figueroa I, Santos MJ, Pego-Reigosa JM, Nero P, Cerqueira M, Duarte C, Miranda LC, Bernardes M, Gonçalves MJ, Mouriño-Rodríguez C, Araújo F, Raposo A, Barcelos A, Couto M, Abreu P, Otón-Sanchez T, Macieira C, Ramos F, Branco JC, Silva JAP, Canhão H, Calvo-Alén J, Rheumatic Diseases Registry of the Portuguese Society of Rheumatology, Registry of Systemic Lupus Erythematosus Patients of the Spanish Society of Rheumatology. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort. Arthritis Care Res (Hoboken). 2015 Aug;67(8):1180–5. PMID: 25581417. DOI: 10.1002/acr.22539. IF2015: 3.229; Q2. http://www.ncbi.nlm.nih.gov/pubmed/25581417
Enlace

Nishishinya MB, Pereda CA, Muñoz-Fernández S, Pego-Reigosa JM, Rúa-Figueroa I, Andreu J-L, Fernández-Castro M, Rosas J, Loza Santamaría E. Identification of lymphoma predictors in patients with primary Sjögren’s syndrome: a systematic literature review and meta-analysis. Rheumatol Int. 2015 Jan;35(1):17–26. PMID: 24899571. DOI: 10.1007/s00296-014-3051-x. IF2015: 1.702; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24899571
Enlace

Pego-Reigosa JM, Rúa-Figueroa Í, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, del Campo V, García-Yébenes MJ, Loza-Santamaría E, Blanco R, Melero-González R, Vela-Casasempere P, Otón-Sánchez T, Tomero-Muriel E, Uriarte-Isacelaya E, Fito-Manteca MC, Freire-González M, Narváez J, Fernández-Nebro A, Zea-Mendoza A, Rosas J, Carlos Rosas J, RELESSER Group from the SS of RSADSG (EASSER). Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus. Lupus. 2015 Jun;24(7):720–9. PMID: 25516473. DOI: 10.1177/0961203314563818. IF2015: 2.118; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25516473
Enlace

Rúa-Figueroa Í, Richi P, López-Longo FJ, Galindo M, Calvo-Alén J, Olivé-Marqués A, Loza-Santamaría E, Vicente SP, Erausquin C, Tomero E, Horcada L, Uriarte E, Sánchez-Atrio A, Rosas J, Montilla C, Fernández-Nebro A, Rodríguez-Gómez M, Vela P, Blanco R, Freire M, Silva L, Díez-Álvarez E, Ibáñez-Barceló M, Zea A, Narváez J, Martínez-Taboada V, Marenco JL, de Castro MF, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas JJ, Pecondón Á, Marras C, Carreira P, Bonilla G, Torrente V, Castellví I, Alegre J, Moreno M, Raya E, de la Peña PG, Vázquez T, Aguirre Á, Quevedo V, Pego-Reigosa JM, EAS-SER (Systemic Diseases Study Group of the Spanish Society of Rheumatology). Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences. Medicine (Baltimore). 2015 Jan;94(1):e267. PMID: 25569641. DOI: 10.1097/MD.00000000000002
Enlace

Serrano-Aguilar P, Trujillo-Martin M del M, Pérez de la Rosa A, Cuellar-Pompa L, Saavedra-Medina H, Linertova R, Perestelo-Perez L, Perez-Ramos J, Rivero-Santana A, Spanish SLE CPG Development Group (JM Pego-Reigosa; N Martínez-López de Castro). Patient participation in a Clinical Guideline Development for Systemic Lupus Erythematosus. Patient Educ Couns. 2015 Sep;98(9):1156–63. PMID: 26095343. DOI: 10.1016/j.pec.2015.05.022. IF2015: 2.232; D1. http://www.ncbi.nlm.nih.gov/pubmed/26095343
Enlace

Grupo de trabajo de la Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico, Alarcón-Torres I, Calvo-Alén J, Cuadrado-Lozano MJ, del Pino Sedeño TM, Frutos-Sanz MÁ, García-Díaz S, Jarque-Ramos I, Martín-Gómez MA, Martínez-Ibáñez MT, Martínez-López de Castro N, Melwani PM, Pazos-Casal P, Pego-Reigosa JM, Rúa-Figueroa Fernández de Larrinoa I, Ruíz-Irastorza G, Serrano-Aguilar P, Sabio Sánchez JM. Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico. Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluación del Servicio Canario de la Salud; 2015. Guías de Práctica Clínica en el SNS.; 2015. NIPO: 680-15-083-4. ISBN: 9788439380894. http://portal.guiasalud.es/GPC/GPC_549_Lupus_SESCS_compl.pdf
Enlace

Álvarez-Payero M, Martínez López de Castro N, Ucha Samartín M, Martín Vila A, Vázquez López C, Piñeiro Corrales G. Medication non-adherence as a cause of hospital admissions. Farm Hosp. 2014 Jul;38(4):328–33. PMID: 25137166. DOI: 10.7399/fh.2014.38.4.7660. IF: N/A. http://www.ncbi.nlm.nih.gov/pubmed/?term=25137166
Enlace

Cobo-Ibáñez T, Loza-Santamaría E, Pego-Reigosa JM, Marqués AO, Rúa-Figueroa I, Fernández-Nebro A, Cáliz Cáliz R, López Longo FJ, Muñoz-Fernández S. Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review. Semin Arthritis Rheum. 2014 Oct;44(2):175–85. PMID: 24830791. DOI: 10.1016/j.semarthrit.2014.04.002. IF: 3.925; Q1. http://www.ncbi.nlm.nih.gov/pubmed/24830791
Enlace

Fernández-Nebro A, Marenco JL, López-Longo F, Galindo M, Hernández-Cruz BE, Narváez J, Rúa-Figueroa I, Raya-Alvarez E, Zea A, Freire M, Sánchez-Atrio AI, García-Vicuña R, Pego-Reigosa JM, Manrique-Arija S, Nieves-Martín L, Carreño L. The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB). Lupus. 2014 Sep;23(10):1014–22. PMID: 24833667. DOI: 10.1177/0961203314534909. IF: 2.197; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24833667
Enlace

Piñeiro Corrales G, Vazquez Lopez C, Álvarez-Payero M, Vázquez López C, Álvarez Payero M. Efecto del tratamiento farmacológico en el estado nutricional del paciente neurológico [Effect of pharmacologic treatment of the nutritional status of neurologic patients]. Nutr Hosp. 2014 Jan;29 Suppl 2:47–56. PMID: 25077345. IF: 1.040; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25077345
Enlace

Rúa-Figueroa I, López-Longo FJ, Calvo-Alén J, Galindo-Izquierdo M, Loza E, García de Yebenes MJ, Pego-Reigosa JM. National registry of patients with systemic lupus erythematosus of the Spanish Society of Rheumatology: objectives and methodology. Reumatol Clin. 2014 Jan;10(1):17–24. PMID: 23871155. DOI: 10.1016/j.reuma.2013.04.013. IF: N/A. http://www.ncbi.nlm.nih.gov/pubmed/23871155
Enlace

Silva-Fernández L, Loza E, Martínez-Taboada VM, Blanco R, Rúa-Figueroa I, Pego-Reigosa JM, Muñoz-Fernández S, Systemic Autoimmune Diseases Study Group of the Spanish Society for Rheumatology (EAS-SER). Biological therapy for systemic vasculitis: a systematic review. Semin Arthritis Rheum. 2014 Feb;43(4):542–57. PMID: 23978781. DOI: 10.1016/j.semarthrit.2013.07.010. IF: 3.925; Q1. http://www.ncbi.nlm.nih.gov/pubmed/23978781
Enlace

Tejera Segura B, Holgado S, Mateo L, Pego-Reigosa JM, Carnicero Iglesias M, Olivé A. Síndrome de Löfgren: estudio de 80 casos. Med Clin (Barc). 2014 Aug;143(4):166–9. PMID: 24855899. DOI: 10.1016/j.medcli.2014.02.029. IF: 1.417; Q2. http://www.ncbi.nlm.nih.gov/pubmed/24855899
Enlace

Ucha Sanmartin M, Martín Vila A, López Vidal C, Caaamaño Barreiro M, Piñeiro Corrales G. [Prevention of medication errors in healthcare transition of patients treated with apomorphine]. Farm Hosp. 2014 May;38(3):227–30. PMID: 24951908. DOI: 10.7399/fh.2014.38.3.7430. IF: N/A. http://www.ncbi.nlm.nih.gov/pubmed/24951908
Enlace